NAMS MENOPAUSE CERTIFICATION EXAM (MSCP) NEWEST
2026 ACTUAL EXAM| MENOPAUSE CERTIFICATION EXAM
WITH COMPLETE 200 REAL EXAM QUESTIONS AND CORRECT
VERIFIED ANSWERS/ ALREADY GRADED A+ (MOST RECENT!!)
CORE DOMAINS
• Physiology and Pathophysiology of the Menopause Transition
• Symptoms and Clinical Presentation of Menopause
• Health Disorders in Midlife Women
• Treatment Options: Hormonal and Non-Hormonal
• Preventive Care and Patient Counseling
INTRODUCTION
This comprehensive assessment evaluates mastery of menopause management aligned with The
Menopause Society (formerly NAMS) Certified Menopause Practitioner (MSCP) examination blueprint.
The examination assesses foundational and advanced knowledge in the physiology of reproductive
aging, menopause symptoms, health disorders of midlife women, hormonal and non-hormonal
treatment options, and preventive care. Questions are structured as scenario-based multiple-choice
items requiring clinical reasoning, application of evidence-based guidelines, and critical problem-solving.
Emphasis is placed on real-world clinical decision-making, adherence to NAMS position statements, and
patient-centered care. Candidates must demonstrate not only theoretical knowledge but also the ability
to apply concepts to authentic clinical scenarios. This instrument supports both objective assessment
preparation and professional certification validation.
SECTION ONE: QUESTIONS 1–200
Question 1
According to the STRAW+10 staging system, what is the average age of the final menstrual period in
North American women?
A. 45 years
B. 49 years
,C. 51 years
D. 55 years
Correct answer
C. 51 years
RATIONALE: The average age of natural menopause in North American women is approximately 51
years. This is defined as 12 months of amenorrhea following the final menstrual period. Option A is too
early. Option B is below the average. Option D is above the average.
Question 2
A 48-year-old woman presents with irregular menstrual cycles occurring every 35 to 50 days and
occasional hot flashes. According to the STRAW+10 staging system, which stage best describes her
reproductive status?
A. Late reproductive stage
B. Early menopause transition
C. Late menopause transition
D. Early postmenopause
Correct answer
B. Early menopause transition
RATIONALE: The early menopause transition (STRAW stage -2) is characterized by a persistent
difference of 7 days or more in consecutive menstrual cycles. Late transition requires 60 days or more of
amenorrhea. Early postmenopause begins after 12 months of amenorrhea.
Question 3
A 52-year-old woman reports her last menstrual period was 14 months ago. She has hot flashes and
vaginal dryness. According to STRAW+10, which stage is she in?
A. Late menopause transition
B. Early postmenopause
C. Late postmenopause
D. Late reproductive stage
Correct answer
B. Early postmenopause
RATIONALE: Early postmenopause (+1a) is defined as the period from the final menstrual period
through 5 years after the FMP. Since the patient is 14 months past her FMP and has classic symptoms,
she is in the +1a stage. Late postmenopause begins after 5 years.
,Question 4
What is the most reliable clinical indicator for confirming menopause in a woman over age 45?
A. Estradiol level below 20 pg/mL
B. FSH level above 25 mIU/mL
C. Twelve months of amenorrhea
D. Inhibin B below 15 pg/mL
Correct answer
C. Twelve months of amenorrhea
RATIONALE: Twelve months of amenorrhea in a woman of appropriate age is the most reliable
clinical indicator of menopause. Laboratory values can fluctuate during perimenopause and are not
required for confirmation in women over age 45.
Question 5
A 35-year-old woman has not had a menstrual period for 6 months and has an FSH of 48 mIU/mL on two
occasions. What is the most likely diagnosis?
A. Early menopause
B. Premature ovarian insufficiency (POI)
C. Late menopause transition
D. Hypothalamic amenorrhea
Correct answer
B. Premature ovarian insufficiency (POI)
RATIONALE: POI is defined as menopause before age 40, with elevated FSH (greater than 40
mIU/mL) and low estradiol on two occasions 4 to 6 weeks apart. This patient's age and FSH levels are
consistent with POI.
Question 6
In surgical menopause after bilateral oophorectomy, the key clinical consequence is:
A. Gradual symptom onset over 5 years
B. Abrupt estrogen loss leading to severe vasomotor symptoms
C. No change in bone density
D. Weight loss
Correct answer
B. Abrupt estrogen loss leading to severe vasomotor symptoms
, RATIONALE: Surgical menopause results in abrupt estrogen loss, causing immediate and often more
severe vasomotor symptoms compared to natural menopause. The sudden hormonal drop is the key
clinical consequence.
Question 7
A 51-year-old woman reports cycles varying from 24 to 45 days over the past year with occasional hot
flashes. According to STRAW+10, which stage is she in?
A. Early perimenopause (-2)
B. Late perimenopause (-1)
C. Early postmenopause (+1a)
D. Late reproductive (-3b)
Correct answer
A. Early perimenopause (-2)
RATIONALE: Early perimenopause is characterized by variable cycle length (persistent difference of 7
days or more in consecutive cycles). Late perimenopause requires 60 days or more of amenorrhea.
Postmenopause begins after 12 months of amenorrhea.
Question 8
A 49-year-old woman presents with vasomotor symptoms that are disrupting her sleep and work
performance. She has an intact uterus and no contraindications to hormone therapy. According to
NAMS guidelines, which regimen is most appropriate?
A. Oral conjugated estrogens 0.625 mg daily alone
B. Transdermal estradiol 0.05 mg/day plus micronized progesterone 200 mg for 12 days monthly
C. Low-dose vaginal estradiol ring only
D. Paroxetine 7.5 mg daily alone
Correct answer
B. Transdermal estradiol 0.05 mg/day plus micronized progesterone 200 mg for 12 days monthly
RATIONALE: For a woman with an intact uterus, systemic estrogen therapy must be combined with a
progestogen to protect the endometrium. Transdermal estradiol is preferred due to lower venous
thromboembolism risk. Option A is inappropriate because unopposed estrogen increases endometrial
cancer risk. Options C and D are not first-line for systemic vasomotor symptoms.
Question 9
What is the primary indication for systemic menopausal hormone therapy?
2026 ACTUAL EXAM| MENOPAUSE CERTIFICATION EXAM
WITH COMPLETE 200 REAL EXAM QUESTIONS AND CORRECT
VERIFIED ANSWERS/ ALREADY GRADED A+ (MOST RECENT!!)
CORE DOMAINS
• Physiology and Pathophysiology of the Menopause Transition
• Symptoms and Clinical Presentation of Menopause
• Health Disorders in Midlife Women
• Treatment Options: Hormonal and Non-Hormonal
• Preventive Care and Patient Counseling
INTRODUCTION
This comprehensive assessment evaluates mastery of menopause management aligned with The
Menopause Society (formerly NAMS) Certified Menopause Practitioner (MSCP) examination blueprint.
The examination assesses foundational and advanced knowledge in the physiology of reproductive
aging, menopause symptoms, health disorders of midlife women, hormonal and non-hormonal
treatment options, and preventive care. Questions are structured as scenario-based multiple-choice
items requiring clinical reasoning, application of evidence-based guidelines, and critical problem-solving.
Emphasis is placed on real-world clinical decision-making, adherence to NAMS position statements, and
patient-centered care. Candidates must demonstrate not only theoretical knowledge but also the ability
to apply concepts to authentic clinical scenarios. This instrument supports both objective assessment
preparation and professional certification validation.
SECTION ONE: QUESTIONS 1–200
Question 1
According to the STRAW+10 staging system, what is the average age of the final menstrual period in
North American women?
A. 45 years
B. 49 years
,C. 51 years
D. 55 years
Correct answer
C. 51 years
RATIONALE: The average age of natural menopause in North American women is approximately 51
years. This is defined as 12 months of amenorrhea following the final menstrual period. Option A is too
early. Option B is below the average. Option D is above the average.
Question 2
A 48-year-old woman presents with irregular menstrual cycles occurring every 35 to 50 days and
occasional hot flashes. According to the STRAW+10 staging system, which stage best describes her
reproductive status?
A. Late reproductive stage
B. Early menopause transition
C. Late menopause transition
D. Early postmenopause
Correct answer
B. Early menopause transition
RATIONALE: The early menopause transition (STRAW stage -2) is characterized by a persistent
difference of 7 days or more in consecutive menstrual cycles. Late transition requires 60 days or more of
amenorrhea. Early postmenopause begins after 12 months of amenorrhea.
Question 3
A 52-year-old woman reports her last menstrual period was 14 months ago. She has hot flashes and
vaginal dryness. According to STRAW+10, which stage is she in?
A. Late menopause transition
B. Early postmenopause
C. Late postmenopause
D. Late reproductive stage
Correct answer
B. Early postmenopause
RATIONALE: Early postmenopause (+1a) is defined as the period from the final menstrual period
through 5 years after the FMP. Since the patient is 14 months past her FMP and has classic symptoms,
she is in the +1a stage. Late postmenopause begins after 5 years.
,Question 4
What is the most reliable clinical indicator for confirming menopause in a woman over age 45?
A. Estradiol level below 20 pg/mL
B. FSH level above 25 mIU/mL
C. Twelve months of amenorrhea
D. Inhibin B below 15 pg/mL
Correct answer
C. Twelve months of amenorrhea
RATIONALE: Twelve months of amenorrhea in a woman of appropriate age is the most reliable
clinical indicator of menopause. Laboratory values can fluctuate during perimenopause and are not
required for confirmation in women over age 45.
Question 5
A 35-year-old woman has not had a menstrual period for 6 months and has an FSH of 48 mIU/mL on two
occasions. What is the most likely diagnosis?
A. Early menopause
B. Premature ovarian insufficiency (POI)
C. Late menopause transition
D. Hypothalamic amenorrhea
Correct answer
B. Premature ovarian insufficiency (POI)
RATIONALE: POI is defined as menopause before age 40, with elevated FSH (greater than 40
mIU/mL) and low estradiol on two occasions 4 to 6 weeks apart. This patient's age and FSH levels are
consistent with POI.
Question 6
In surgical menopause after bilateral oophorectomy, the key clinical consequence is:
A. Gradual symptom onset over 5 years
B. Abrupt estrogen loss leading to severe vasomotor symptoms
C. No change in bone density
D. Weight loss
Correct answer
B. Abrupt estrogen loss leading to severe vasomotor symptoms
, RATIONALE: Surgical menopause results in abrupt estrogen loss, causing immediate and often more
severe vasomotor symptoms compared to natural menopause. The sudden hormonal drop is the key
clinical consequence.
Question 7
A 51-year-old woman reports cycles varying from 24 to 45 days over the past year with occasional hot
flashes. According to STRAW+10, which stage is she in?
A. Early perimenopause (-2)
B. Late perimenopause (-1)
C. Early postmenopause (+1a)
D. Late reproductive (-3b)
Correct answer
A. Early perimenopause (-2)
RATIONALE: Early perimenopause is characterized by variable cycle length (persistent difference of 7
days or more in consecutive cycles). Late perimenopause requires 60 days or more of amenorrhea.
Postmenopause begins after 12 months of amenorrhea.
Question 8
A 49-year-old woman presents with vasomotor symptoms that are disrupting her sleep and work
performance. She has an intact uterus and no contraindications to hormone therapy. According to
NAMS guidelines, which regimen is most appropriate?
A. Oral conjugated estrogens 0.625 mg daily alone
B. Transdermal estradiol 0.05 mg/day plus micronized progesterone 200 mg for 12 days monthly
C. Low-dose vaginal estradiol ring only
D. Paroxetine 7.5 mg daily alone
Correct answer
B. Transdermal estradiol 0.05 mg/day plus micronized progesterone 200 mg for 12 days monthly
RATIONALE: For a woman with an intact uterus, systemic estrogen therapy must be combined with a
progestogen to protect the endometrium. Transdermal estradiol is preferred due to lower venous
thromboembolism risk. Option A is inappropriate because unopposed estrogen increases endometrial
cancer risk. Options C and D are not first-line for systemic vasomotor symptoms.
Question 9
What is the primary indication for systemic menopausal hormone therapy?
